Egetis Therapeutics AB (publ) (EGTX) — Net Asset Quality Index
Egetis Therapeutics AB (publ) (EGTX) has a Net Asset Quality Index of 46.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr537.40 Million minus total liabilities of Skr288.70 Million yields net assets of Skr248.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Egetis Therapeutics AB (publ) debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Egetis Therapeutics AB (publ) Net Asset Quality Index Over Time (2008–2025)
This chart shows how Egetis Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 46.3%, representing net assets of Skr248.70 Million against total assets of Skr537.40 Million SEK. For live market cap and overall valuation, see Egetis Therapeutics AB (publ) (EGTX) total market value.
Annual Net Asset Quality Index for Egetis Therapeutics AB (publ) (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Egetis Therapeutics AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Egetis Therapeutics AB (publ) PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 53.0% | Skr338.70 Million | Skr639.10 Million | Skr300.40 Million | ▼ -9.2 pp |
| 2024 | 62.2% | Skr492.90 Million | Skr792.30 Million | Skr299.40 Million | ▼ -9.6 pp |
| 2023 | 71.8% | Skr545.60 Million | Skr760.20 Million | Skr214.60 Million | ▼ -18.4 pp |
| 2022 | 90.2% | Skr506.20 Million | Skr561.10 Million | Skr54.90 Million | ▼ -2.4 pp |
| 2021 | 92.6% | Skr527.04 Million | Skr569.27 Million | Skr42.23 Million | ▲ +22.2 pp |
| 2020 | 70.4% | Skr629.63 Million | Skr893.97 Million | Skr264.34 Million | ▼ -20.2 pp |
| 2019 | 90.7% | Skr244.88 Million | Skr270.07 Million | Skr25.20 Million | ▲ +0.0 pp |
| 2018 | 90.6% | Skr219.36 Million | Skr242.04 Million | Skr22.68 Million | ▼ -5.7 pp |
| 2017 | 96.3% | Skr303.71 Million | Skr315.37 Million | Skr11.66 Million | ▼ -2.0 pp |
| 2016 | 98.3% | Skr389.56 Million | Skr396.44 Million | Skr6.87 Million | ▲ +6.5 pp |
| 2015 | 91.7% | Skr48.03 Million | Skr52.36 Million | Skr4.33 Million | ▲ +4.1 pp |
| 2014 | 87.6% | Skr90.66 Million | Skr103.47 Million | Skr12.81 Million | ▼ -4.4 pp |
| 2013 | 92.0% | Skr46.95 Million | Skr51.01 Million | Skr4.06 Million | ▲ +2.8 pp |
| 2012 | 89.2% | Skr53.94 Million | Skr60.46 Million | Skr6.52 Million | ▼ -6.5 pp |
| 2011 | 95.7% | Skr87.53 Million | Skr91.42 Million | Skr3.89 Million | ▲ +13.4 pp |
| 2010 | 82.3% | Skr6.99 Million | Skr8.49 Million | Skr1.50 Million | ▼ -13.1 pp |
| 2009 | 95.4% | Skr5.64 Million | Skr5.91 Million | Skr273.98K | ▲ +1.4 pp |
| 2008 | 94.0% | Skr5.05 Million | Skr5.37 Million | Skr323.55K | — |